Niraparib API Industry Research Report 2025
Description
Summary
According to APO Research, the global Niraparib API market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Niraparib API include Nantong Changyou Pharmaceutical Technology, Asymchem, WuXi STA, Valary Lab, SynZeal Research, Jigs chemical, Dr. Reddy's Laboratories and Bulat Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Niraparib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Niraparib API.
The report will help the Niraparib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Niraparib API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Niraparib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Niraparib API Segment by Company
Nantong Changyou Pharmaceutical Technology
Asymchem
WuXi STA
Valary Lab
SynZeal Research
Jigs chemical
Dr. Reddy's Laboratories
Bulat Pharmaceutical
Niraparib API Segment by Type
0.98
0.99
Niraparib API Segment by Application
Tablets
Capsules
Other
Niraparib API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niraparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Niraparib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Niraparib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Niraparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Niraparib API market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Niraparib API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Niraparib API include Nantong Changyou Pharmaceutical Technology, Asymchem, WuXi STA, Valary Lab, SynZeal Research, Jigs chemical, Dr. Reddy's Laboratories and Bulat Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Niraparib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Niraparib API.
The report will help the Niraparib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Niraparib API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Niraparib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Niraparib API Segment by Company
Nantong Changyou Pharmaceutical Technology
Asymchem
WuXi STA
Valary Lab
SynZeal Research
Jigs chemical
Dr. Reddy's Laboratories
Bulat Pharmaceutical
Niraparib API Segment by Type
0.98
0.99
Niraparib API Segment by Application
Tablets
Capsules
Other
Niraparib API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niraparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Niraparib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Niraparib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Niraparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
122 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Niraparib API Market Size (2020-2031)
- 2.2.2 Global Niraparib API Sales (2020-2031)
- 2.2.3 Global Niraparib API Market Average Price (2020-2031)
- 2.3 Niraparib API by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 0.98
- 2.3.3 0.99
- 2.4 Niraparib API by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Tablets
- 2.4.3 Capsules
- 2.4.4 Other
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Niraparib API Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Niraparib API Sales (Tons) of Manufacturers (2020-2025)
- 3.3 Global Niraparib API Revenue of Manufacturers (2020-2025)
- 3.4 Global Niraparib API Average Price by Manufacturers (2020-2025)
- 3.5 Global Niraparib API Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Niraparib API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Niraparib API, Product Type & Application
- 3.8 Global Manufacturers of Niraparib API, Established Date
- 3.9 Global Niraparib API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Nantong Changyou Pharmaceutical Technology
- 4.1.1 Nantong Changyou Pharmaceutical Technology Company Information
- 4.1.2 Nantong Changyou Pharmaceutical Technology Business Overview
- 4.1.3 Nantong Changyou Pharmaceutical Technology Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Nantong Changyou Pharmaceutical Technology Niraparib API Product Portfolio
- 4.1.5 Nantong Changyou Pharmaceutical Technology Recent Developments
- 4.2 Asymchem
- 4.2.1 Asymchem Company Information
- 4.2.2 Asymchem Business Overview
- 4.2.3 Asymchem Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Asymchem Niraparib API Product Portfolio
- 4.2.5 Asymchem Recent Developments
- 4.3 WuXi STA
- 4.3.1 WuXi STA Company Information
- 4.3.2 WuXi STA Business Overview
- 4.3.3 WuXi STA Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 WuXi STA Niraparib API Product Portfolio
- 4.3.5 WuXi STA Recent Developments
- 4.4 Valary Lab
- 4.4.1 Valary Lab Company Information
- 4.4.2 Valary Lab Business Overview
- 4.4.3 Valary Lab Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Valary Lab Niraparib API Product Portfolio
- 4.4.5 Valary Lab Recent Developments
- 4.5 SynZeal Research
- 4.5.1 SynZeal Research Company Information
- 4.5.2 SynZeal Research Business Overview
- 4.5.3 SynZeal Research Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 SynZeal Research Niraparib API Product Portfolio
- 4.5.5 SynZeal Research Recent Developments
- 4.6 Jigs chemical
- 4.6.1 Jigs chemical Company Information
- 4.6.2 Jigs chemical Business Overview
- 4.6.3 Jigs chemical Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Jigs chemical Niraparib API Product Portfolio
- 4.6.5 Jigs chemical Recent Developments
- 4.7 Dr. Reddy's Laboratories
- 4.7.1 Dr. Reddy's Laboratories Company Information
- 4.7.2 Dr. Reddy's Laboratories Business Overview
- 4.7.3 Dr. Reddy's Laboratories Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Dr. Reddy's Laboratories Niraparib API Product Portfolio
- 4.7.5 Dr. Reddy's Laboratories Recent Developments
- 4.8 Bulat Pharmaceutical
- 4.8.1 Bulat Pharmaceutical Company Information
- 4.8.2 Bulat Pharmaceutical Business Overview
- 4.8.3 Bulat Pharmaceutical Niraparib API Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Bulat Pharmaceutical Niraparib API Product Portfolio
- 4.8.5 Bulat Pharmaceutical Recent Developments
- 5 Global Niraparib API Market Scenario by Region
- 5.1 Global Niraparib API Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Niraparib API Sales by Region: 2020-2031
- 5.2.1 Global Niraparib API Sales by Region: 2020-2025
- 5.2.2 Global Niraparib API Sales by Region: 2026-2031
- 5.3 Global Niraparib API Revenue by Region: 2020-2031
- 5.3.1 Global Niraparib API Revenue by Region: 2020-2025
- 5.3.2 Global Niraparib API Revenue by Region: 2026-2031
- 5.4 North America Niraparib API Market Facts & Figures by Country
- 5.4.1 North America Niraparib API Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Niraparib API Sales by Country (2020-2031)
- 5.4.3 North America Niraparib API Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Niraparib API Market Facts & Figures by Country
- 5.5.1 Europe Niraparib API Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Niraparib API Sales by Country (2020-2031)
- 5.5.3 Europe Niraparib API Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Niraparib API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Niraparib API Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Niraparib API Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Niraparib API Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Niraparib API Market Facts & Figures by Country
- 5.7.1 South America Niraparib API Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Niraparib API Sales by Country (2020-2031)
- 5.7.3 South America Niraparib API Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Niraparib API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Niraparib API Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Niraparib API Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Niraparib API Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Niraparib API Sales by Type (2020-2031)
- 6.1.1 Global Niraparib API Sales by Type (2020-2031) & (Tons)
- 6.1.2 Global Niraparib API Sales Market Share by Type (2020-2031)
- 6.2 Global Niraparib API Revenue by Type (2020-2031)
- 6.2.1 Global Niraparib API Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Niraparib API Revenue Market Share by Type (2020-2031)
- 6.3 Global Niraparib API Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Niraparib API Sales by Application (2020-2031)
- 7.1.1 Global Niraparib API Sales by Application (2020-2031) & (Tons)
- 7.1.2 Global Niraparib API Sales Market Share by Application (2020-2031)
- 7.2 Global Niraparib API Revenue by Application (2020-2031)
- 7.2.1 Global Niraparib API Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Niraparib API Revenue Market Share by Application (2020-2031)
- 7.3 Global Niraparib API Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Niraparib API Value Chain Analysis
- 8.1.1 Niraparib API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Niraparib API Production Mode & Process
- 8.2 Niraparib API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Niraparib API Distributors
- 8.2.3 Niraparib API Customers
- 9 Global Niraparib API Analyzing Market Dynamics
- 9.1 Niraparib API Industry Trends
- 9.2 Niraparib API Industry Drivers
- 9.3 Niraparib API Industry Opportunities and Challenges
- 9.4 Niraparib API Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
